Skip to main content
SpringerLink
Log in

Cerebrovascular Aspects of Glycoprotein IIb/IIIa Receptor Inhibitors

  • Chapter
Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 108 Accesses

Abstract

Ischemic and hemorrhagic subtypes of stroke are important complications of treatments for cardiac disease, as they impact significantly on patient management and outcome. Their frequency varies with the characteristics of the patient population under study, the procedures involved, and the combination and intensity of antiplatelet, antithrombotic, and fibrinolytic strategies employed. Understanding the mechanisms contributing to the various stroke subtypes is important, not only to improve the overall outcome for patients with cardiac disease, but also to translate similar strategies to patients with cerebrovascular disease, for whom the risk-to-benefit ratio is more acute.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Longstreth WT, Litwin PE, Weaver WD. Myocardial infarction, thrombolytic therapy, and stroke. Stroke 1993;24:587–590.

    Article  PubMed  Google Scholar 

  2. Sloan MA, Price TR, Terrin ML, et al. Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience. Stroke 1997:28:1107–1114.

    Article  PubMed  CAS  Google Scholar 

  3. Mahaffey KW, Granger CB, Sloan MA, et al. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. Circulation 1998;97:757–764.

    Article  PubMed  CAS  Google Scholar 

  4. Gore JM, Granger CB, Simoons ML, et al. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Circulation 1995;92:2811–2818.

    Article  PubMed  CAS  Google Scholar 

  5. The GUSTO IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996;335:775–782.

    Article  Google Scholar 

  6. Mahaffey KW, Harrington RA, Simoons ML, et al. Stroke in patients with acute coronary syndromes: incidence and outcomes in the Platelet Glycoprotein llb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial. Circulation 1999;99:2371–2377.

    Article  PubMed  CAS  Google Scholar 

  7. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB Trial. Circulation 1994;89:1545–1556.

    Article  Google Scholar 

  8. Sila CA. Neurologic complications of vascular surgery. Neurol Clin North Am 1998;16:9–20.

    CAS  Google Scholar 

  9. Dawson DM, Fischer EG. Neurologic complications of cardiac catheterization. Neurology 1977;27: 496–497.

    Article  PubMed  CAS  Google Scholar 

  10. Kosmorsky G, Hanson MR, Tomsak RL. Neuro-ophthalmologic complications of cardiac catheterization. Neurology 1988;38:483–485.

    Article  PubMed  CAS  Google Scholar 

  11. Galbreath C, Salgado ED, Furlan AJ, Hollman J. Central nervous system complications of percutaneous transluminal coronary angioplasty. Stroke 1986;17:616–619.

    Article  PubMed  CAS  Google Scholar 

  12. Akkerhuis KM, Deckers JW, Lincoff AM, et al. Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. JAMA 2001;286:78–82.

    Article  PubMed  CAS  Google Scholar 

  13. The Gusto Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673–682.

    Article  Google Scholar 

  14. Babikian VL, Kase CS, Pessin MS, Norrving B, Gorelick PB. Intracerebral hemorrhage in stroke patients anticoagulated with heparin. Stroke 1989;20:1500–1503.

    Article  PubMed  CAS  Google Scholar 

  15. Cerebral Embolism Study Group. Cardiogenic stroke, early anticoagulation, and brain hemorrhage. Arch Intern Med 1987;147:636–639.

    Article  Google Scholar 

  16. Shields RW Jr, Laureno R, Lachman T, Victor M. Anticoagulant-related hemorrhage in acute cerebral embolism. Stroke 1984;15:426–437.

    Article  PubMed  Google Scholar 

  17. Boersma E, Harrington RA, Molitemo DJ, et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinical trials. Lancet 2002;359:189–198.

    Article  PubMed  CAS  Google Scholar 

  18. Gebel J, Sila CA, Sloan MA, et al. Thrombolysis-related intracranial hemorrhage. A radiographic analysis of 244 cases from the GUSTO-I trial with clinical correlation. Stroke 1998;29:563–569.

    Article  PubMed  CAS  Google Scholar 

  19. Vaitkus PT, Berlin JA, Schwartz JS, Barnathan ES. Stroke complicating acute myocardial infarction-a meta-analysis of risk modification by anticoagulation and thrombolytic therapy. Arch Intern Med 1992; 152:2020–2024.

    Article  PubMed  CAS  Google Scholar 

  20. Sloan MA, Sila CA, Mahaffey KW, et al. Prediction of 30-d mortality among patients with thrombolysis-related intracranial hemorrhage. Circulation 1998;14:1376–1382.

    Article  Google Scholar 

  21. Widjicks EFM, Jack C. Intracerebral hemorrhage after fibrinolytic therapy for acute myocardial infarction. Stroke 1993;24:554–557.

    Article  Google Scholar 

  22. Ohman EM, Kleiman NS, Gacioch G, et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein integrin receptor blockade with integrilin in acute myocardial infarction. Circulation 1997;95:846–854.

    Article  PubMed  CAS  Google Scholar 

  23. Topol EJ, for the GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomized trial. Lancet 2001;357:1898–1899.

    Article  Google Scholar 

  24. The ASSENT-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abcisimab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001;358:605–613.

    Article  Google Scholar 

  25. SoRelle R. SmithKline Beecham halts tests of lotrafiban, an oral glycoprotein IIb/IIIa inhibitor. Circulation 2001;103:E9001–E9002.

    Article  Google Scholar 

  26. Hass WK, Easton JD, Adams HP, et al., for the Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med 1989;321:501–507.

    Article  PubMed  CAS  Google Scholar 

  27. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329–1339.

    Article  Google Scholar 

  28. Bennett CL, Weinberg PD, Rozenberg-Ben-Dror K, Yarnold PR, Kwaan HC, Green D. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med 1998;128: 541–544.

    Article  PubMed  CAS  Google Scholar 

  29. American-Canadian Co-operative Study Group. Persantin aspirin trial in cerebral ischemia. Part II. Endpoint results. Stroke 1983;16:406–415.

    Google Scholar 

  30. Bousser MG, Eschwege E, Hagenaah M, et al. AICLA controlled trial of aspirin and diypridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983;14:5–14.

    Article  PubMed  CAS  Google Scholar 

  31. ESPS Group. European Stroke Prevention Study. Stroke 1990;21:1122–1130.

    Article  Google Scholar 

  32. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1–13.

    Article  PubMed  CAS  Google Scholar 

  33. CAVATAS Investigators. Endovascular vs surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study: a randomized trial. Lancet 2001;357:1729–1737.

    Article  Google Scholar 

  34. Alberts MJ (for the Publications Committee). Results of a multicenter prospective randomized trial of carotid artery stenting vs carotid endarterectomy. Stroke 2001;32:325 (abstract).

    Google Scholar 

  35. Qureshi AI, Ali Z, Suri MF, et al. Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement. Neurosurgery 2001;48:998–1005.

    Article  PubMed  CAS  Google Scholar 

  36. Schneiderman J, Morag B, Gerniak A, et al. Abciximab in carotid stenting for postsurgical carotid restenosis: immediate results. J Endovasc Ther 2000;7:263–272.

    Article  PubMed  CAS  Google Scholar 

  37. Kapadia SR, Bajzer CT, Ziada KM, et al. Initial experience with platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. Stroke 2001;32: 2328–2332.

    Article  PubMed  CAS  Google Scholar 

  38. Hopkins LN for the SSYLVIA Trial Investigators, American Society of Interventional and Therapeutic Neuroradiology Meeting, February, 2002.

    Google Scholar 

  39. Rasmussen PA, Perl J, Barr JD, et al. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience. J Neurosurg 2000;92:771–778.

    Article  PubMed  CAS  Google Scholar 

  40. Chinese Acute Stroke Trial Collaborative Group. Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet 1997;349:1641–1649.

    Article  Google Scholar 

  41. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischemic stroke. Lancet 1997;349:1569–1581.

    Article  Google Scholar 

  42. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.

    Article  Google Scholar 

  43. Donnan GA, Davis SM, Chambers BR, et al. Streptokinase for acute ischemic stroke with relationship to time of administration. JAMA 1996;276:961–966.

    Article  PubMed  CAS  Google Scholar 

  44. The Multicentre Acute Stroke Trial-Europe Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med 1996;335:145–150.

    Article  Google Scholar 

  45. Multicentre Acute Stroke Trial—Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke. Lancet 1995;346:1509–1514.

    Google Scholar 

  46. delZoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. Proact: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4–11.

    Article  CAS  Google Scholar 

  47. Kase CS, Furlan AJ, Wechsler LR, et al. Symptomatic intracerebral hemorrhage after intra-arterial thrombolysis with prourokinase in acute ischemic stroke: the PROACT II trial. Neurology 2001;57:1603–1610.

    Article  PubMed  CAS  Google Scholar 

  48. Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke: a randomized, doubleblind, placebo-controlled, dose-escalation study. Stroke 2000;31:2526–2527.

    Google Scholar 

  49. Junghans U, Seitz RJ, Aulich A, Freund HJ, Siebler M. Bleeding risk of tirofiban, a nonpeptide GP IIb/ Ma platelet receptor antagonist in progressive stroke: an open pilot study. Cerebrovasc Dis 2001;12: 308–312.

    Article  PubMed  CAS  Google Scholar 

  50. Lee KY, Heo JH, Lee SI, Yoon PH. Rescue treatment with abciximab in acute ischemic stroke. Neurology 2001;56:1585–1587.

    Article  PubMed  CAS  Google Scholar 

  51. Wallace RC, Furlan AJ, Moliterno DJ, Stevens GHJ, Masaryk TJ, Perl J. Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIb/IIIa receptor inhibitor. AJNR 1997;18:1257–1260.

    PubMed  CAS  Google Scholar 

  52. Koroshetz W, et al. Intra-arterial thrombolysis: combined Glib/lIla antagonist with rt-PA. Stroke 2002 (abstract).

    Google Scholar 

Download references

Authors
  1. Cathy A. Sila MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, OH, USA

    A. Michael Lincoff MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sila, C.A. (2003). Cerebrovascular Aspects of Glycoprotein IIb/IIIa Receptor Inhibitors. In: Lincoff, A.M. (eds) Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-376-7_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-376-7_20

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-408-1

  • Online ISBN: 978-1-59259-376-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation